Microorganisms (Sep 2024)

Empyema Necessitatis Caused by <i>Prevotella melaninogenica</i> and <i>Dialister pneumosintes</i> Resolved with Vacuum-Assisted Closure System: A Case Report

  • Esteban Bladimir Martínez Castrejón,
  • Erika Reina-Bautista,
  • Sandra Tania Ventura-Gómez,
  • Araceli Maldonado Cisneros,
  • Jessica Alejandra Juárez Ramos,
  • Miguel Alejandro Sánchez Durán,
  • Jesús Aguilar Ventura,
  • Omar Esteban Valencia-Ledezma,
  • María Guadalupe Frías-De-León,
  • Eduardo García Salazar,
  • Carlos Alberto Castro-Fuentes

DOI
https://doi.org/10.3390/microorganisms12091881
Journal volume & issue
Vol. 12, no. 9
p. 1881

Abstract

Read online

Empyema necessitatis is a rare complication of an untreated or inadequately controlled empyema. We present the case of an 11-year-old female adolescent living in precarious conditions, overcrowding, incomplete vaccinations, irregular dental hygiene, and no significant family or personal medical history. The patient started with symptoms one week prior to her hospitalization, presenting a persistent sporadic dry cough, and was later diagnosed with complicated pneumonia, resulting in the placement of an endopleural tube. Vancomycin (40 mg/kg/day) and ceftriaxone (75 mg/kg/day) were administered. However, the clinical evolution was unfavorable, with fever and respiratory distress, so a right jugular catheter was placed. The CT scan showed a loculated collection that occupied the entire right lung parenchyma and pneumothorax at the right upper lobe level. After four days of treatment, the patient still presented purulent drainage with persistent right pleural effusion syndrome. P. melaninogenica and D. pneumosintes were identified from the purulent collection on the upper right lobe, so the antimicrobial treatment was adapted to a glycopeptide, Teicoplanin, at a weight-based dosing of 6 mg/kg/day and Metronidazole at a weight-based dosing of 30 mg/kg/day. In addition, VAC therapy was used for 26 days with favorable resolution.

Keywords